Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: Role in the hyperdynamic circulation

Hepatology

Volumn 27, Issue 1, 1998, Pages 20-27

  Hou, M C ^a   Cahill, P A ^a   Zhang, S ^a   Wang, Y N ^a   Hendrickson, R J ^a   Redmond, E M ^a   Sitzmann, J V ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HEMODYNAMICS; HYPEREMIA; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLANCHNIC BLOOD FLOW; SUPERIOR MESENTERIC ARTERY; VASCULAR RESISTANCE;

EID: 0031961750     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270105     Document Type: Article

References (40)

1. 1 Reichen J. Liver function and pharmacological considerations in the pathogenesis and treatment of portal hypertension. Hepatology 1990 ; 11: 1066–1078. MEDLINE
2. 2 Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal‐hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983 ; 244: G52–G57. MEDLINE
3. 3 Sitzmann JV, Li SS, Lin PW. PGI 2 mediates splanchnic vascular response to norepinephrine in portal hypertension. J Surg Res 1989 ; 7: 208–211.
4. 4 Cahill PA, Foster C, Redmond EM, Gingalewski C, Wu Y, Sitzmann JV. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 1995 ; 22: 598–606. MEDLINE
5. 5 Castro A, Jimenez W, Claria J, Martinez J, Bosch J, Arroyo AV, Piulats J, et al. Impaired responsiveness to angiotensin II experimental cirrhosis: role of nitric oxide. Hepatology 1993 ; 18: 367–372. MEDLINE
6. 6 Kiel JW, Potts L, Benoit JN, Granger DN, Shepherd AP. Reduced vascular sensitivity to norepinephrine in portal hypertensive rats. Am J Physiol 1985 ; 248: G192–G195. MEDLINE
7. 7 Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991 ; 43: 109–142. MEDLINE
8. 8 Pizueta MP, Pique M, Bosch JM, Whittle BJR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic vascular circulation of rats with portal hypertension. Br J Pharmacol 1992 ; 105: 184–190. MEDLINE
9. 9 Ros J, Jimenez W, Lamas L, Claria J, Arroyo V, Rivera F, Rodes J. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 1995 ; 21: 554–560. MEDLINE
10. 10 Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann JV. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol 1996 ; 25: 370–378. MEDLINE
11. 11 Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992 ; 103: 235–239. MEDLINE
12. 12 Sogni P, Moreau R, Oshuga M, Cailmail S, Olerti F, Hadengue A, Pussard E, Lebrec D. Evidence of normal nitric oxide‐mediated vasodilation in conscious rats with cirrhosis. Hepatology 1992 ; 16: 980–986. MEDLINE
13. 13 Wu Y, Burns RC, Sitzmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamic in portal hypertension. Hepatology 1993 ; 18: 1416–1421. MEDLINE
14. 14 Iwata F, Joh I, Kawai K, Itoh M. Role of EDRF in superior mesenteric artery blood flow of normal and chronic portal hypertensive rats. Am J Physiol 1992 ; 263: G149. MEDLINE
15. 15 Sitzmann JV, Bulkley GB, Mitchell M, Campbell K. Role of PGI 2 in the splanchnic hyperaemia contributing to portal hypertension. Ann Surg 1988 ; 209: 322–327.
16. 16 Bruix J, Bosch J, Kravetz D, Mastai R, Rodes J. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. Gastroenterology 1985 ; 88: 430–435. MEDLINE
17. 17 Hamilton G, Phing RCF, Hutton RA, Dandona P, Hobbs KEF. The relationship between prostacyclin activity and pressure in the portal vein. Hepatology 1982 ; 2: 236–242. MEDLINE
18. 18 Fernandez M, Garcia‐Pagan JC, Casadevall M, Mourelle MI, Pique JM, Bosch J, Rodes J. Acute and chronic cyclooxygenase blockade in portal‐ hypertensive rats: Influence on nitric oxide biosynthesis. Gastroenterology 1996 ; 110: 1529–1535. MEDLINE
19. 19 Smith WL. Prostaglandin biosynthesis and its compartmentalization in vascular smooth muscle and endothelial cells. Ann Rev Physiol 1988 ; 48: 251–261.
20. 20 Davies PB, Bailey PJ, Goldenberg MM, Ford‐Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Ann Rev Immunol 1984 ; 2: 335–357.
21. 21 Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on PGI 2 production by cultured human endothelial cells. Science 1984 ; 227: 1477–1479.
22. 22 Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, et al. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Archiv Biochem Biophysics 1993 ; 2: 361–368.
23. 23 Raz A, Wyche A, Fy J, Seibert K, Needleman P. Regulation of prostanoid synthesis in human fibroblasts and human blood cells by interleukin‐1, endotoxin, and glucocorticoids. Adv Prostaglandin Thromboxane Leukot Res 1990 ; 20: 22–27. MEDLINE
24. 24 Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T. Induction of cyclooxygenase‐2 by interleukin‐1 a. Evidence for post‐transcriptional regulation. J Biol Chem 1994 ; 269: 11769–11775. MEDLINE
25. 25 Isakson P, Hauser S, Zhang Y, Leahy K, Masferrer J, Seibert K. Cytokine regulation of eicosanoid generation. Ann N Y Acad Sci 1994 ; 744: 181–183. MEDLINE
26. 26 Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein dye binding. Ann Biochem 1976 ; 72: 248–254.
27. 27 Cracia‐Estan J, Atucha MN, Sabio JM, Vargas F, Quesada T, Romero JC. Increased endothelium‐dependent renal vasodilation in cirrhotic rats. Am J Physiol 1994 ; 267: R549–R553. MEDLINE
28. 28 Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985 ; 248: G618–G625. MEDLINE
29. 29 Hartleb M, Moreau R, Cailmail S, Gaudin C, Lebrec D. Vascular hyporesponsiveness to endothelin‐1 in rats with cirrhosis. Gastroenterology 1994 ; 107: 1085–1093. MEDLINE
30. 30 Garcia‐Pagan JC, Fernandez M, Bernadich PP, Pique JM, Bosch J, Rodes J. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. Am J Physiol 1994 ; 267: G984–G990. MEDLINE
31. 31 Hori N, Groszmann RJ. Direct evidence for increased functional activity of eNOS in the superior mesenteric arterial (SMA) beds of portal hypertensive rats [Abstract]. Hepatology 1996 ; 24: 749A.
32. 32 Berthiaume F, Frangos JA. Flow‐induced prostacyclin production is mediated by a pertussis toxin‐sensitive G‐protein. FEBS Lett 1992 ; 308: 277–279. MEDLINE
33. 33 Malmqvist U, Arner A. Isoform distribution and tissue contents of contractile and cytoskeletal proteins in hypertrophied smooth muscle from rat portal vein. Circ Res 1990 ; 66: 832–845. MEDLINE
34. 34 Jeremy JY, Mikhailidis DM, Karatapanis S, Harry D, Burroughs AK, McIntyre N, Stansby G, et al. Altered prostacyclin synthesis by aortae from hepatic portal vein‐constricted rats; evidence for effects on protein kinase C and calcium. J Hepatol 1994 ; 21: 1017–1022. MEDLINE
35. 35 Matsumoto M, Ohki K, Nagai I, Oshibuchi T. Lung traction causes an increase in plasma prostacyclin concentration and decrease in mean arterial blood pressure. Anesth Analg 1992 ; 75: 773–776. MEDLINE
36. 36 Vandenburgh HH, Hatfaludy S, Sohar I, Shansky J. Stretch‐induced prostaglandins and protein turnover in cultured skeletal muscle. Am J Physiol 1990 ; 259: C232–240. MEDLINE
37. 37 Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Valardell F, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis:relationship to endotoxemia. Hepatology 1993 ; 18: 1139–1143. MEDLINE
38. 38 Lopez‐Talevera JC, Merrill W, Groszmann RJ. Treatment with anti‐ tumor necrosis factor‐a polyclonal antibodies prevents the development of the hyperdynamic circulation and reduces portal pressure in portal hypertensive rats. Hepatology 1993 ; 18: 140–336.
39. 39 Topper JN, Cai J, Falb D, Gimbrone MA. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase‐2, manganese superoxide dismutase and endothelial nitric oxide synthase are selectively up‐regulated by steady laminar shear stress. Proc Natl Acad Sci U S A 1996 ; 93: 10417–10422. MEDLINE
40. 40 Fernandez M, Pagan JC, Casadevall M, Bernadich C, Piera C, Whittle B, Pique JM, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal‐hypertensive rats. Gastroenterology 1995 ; 108: 1487–1495. MEDLINE